Business
PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement
- Application represents milestone toward broadening patient access to inFoods IBS - inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif. , May 07, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company dedicated to the development of advanced diagnostic products, announced that the Company and its CLIA laboratory partner have submitted an application to the American Medi
About this update from Biomerica, Inc.
[{"type":"image","alt":"Biomerica, Inc.","displaySize":"","headline":null,"caption":"Biomerica, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":232,"height":39,"url":"https://media.zenfs.com/en/globenewswire.com/af40ff522792b4c3d1be4034218ddeca"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/m66J9gaNGHXIlBdKngBmxQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTcxO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/af40ff522792b4c3d1be4034218ddeca","width":232,"height":39}},"lazy":false},{"type":"text","content":"- Application represents milestone toward broadening patient access to inFoods IBS","length":82,"tagName":"p"},{"type":"text","content":"- inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, and constipation","length":135,"tagName":"p"},{"type":"text","content":"IRVINE, Calif. , May 07, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company dedicated to the development of advanced diagnostic products, announced that the Company and its CLIA laboratory partner have submitted an application to the American Medical Association (AMA) CPT Editorial Panel requesting the assignment of a Proprietary Laboratory Analysis (PLA) code for the inFoods® IBS diagnostic test. If granted, the PLA code will provide a test-specific code to submit claims to Medicare and other insurers. The PLA code would represent a next step on the pathway to expand patient access to the inFoods IBS product, a personalized test and therapy for treating Irritable Bowel Syndrome (IBS).","length":728,"tagName":"p"},{"type":"text","content":"Strategic Milestone to Expand Patient Access ","length":44,"tagName":"p"},{"type":"text","content":"The PLA code application supports Biomerica’s commercialization strategy to facilitate access to the inFoods® IBS test. The establishment of a PLA code for inFoods® IBS will allow for transparency in claims submission and adjudication for inFoods® IBS, and is a step towards enabling substantially more patients to benefit from the test.","length":337,"tagName":"p"},{"type":"text","content":"“Submitting the PLA code application is indicative of our growth strategy,” said Zack Irani, CEO of Biomerica. “Insurance reimbursement is essential to accelerating physician adoption, expanding patient access, and ultimately unlocking the full ...